Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Durham › NPI 1114978582
Clinic

Lincoln Community Health Center Incorporated

Lincoln Community Health Center Incorporated was paid $18.31M by Medicaid between Jan 2018 and Dec 2024, across 110 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 67% of everything it billed.

33Billing provider infoLINCOLN COMMUNITY HEALTH CENTER INCORPORATED
DURHAM, NC 27707
33aNPI1114978582assigned 05/12/2006
28Total paid$18.31M
24GClaims802,252
24DCodes billed110
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Federally Qualified Health Center (FQHC) providers in North Carolina

Rank by total paid#2 of 324
Median peer was paid$279K
This provider vs. median66×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201842,177$1.96M
201944,848$2.08M
202036,561$1.74M
202193,848$2.80M
2022160,089$2.79M
2023179,479$2.73M
2024incomplete245,250$4.20M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 67% 121,346 101,436 $12.18M
99199 Unlisted special service, procedure or report 12% 416,121 242,105 $2.28M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 3.4% 7,855 6,808 $618K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 2.8% 6,540 5,748 $506K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 2.5% 5,900 5,080 $452K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 2.2% 34,410 29,133 $402K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.8% 4,362 3,689 $337K
90472 Immunization administration, each additional vaccine (list separately) 1.7% 16,667 14,106 $312K
D0145 Oral evaluation for a patient under three years of age <1% 4,685 4,194 $147K
80061 Lipid panel <1% 7,541 6,610 $90K
83036 Hemoglobin; glycosylated (A1C) <1% 13,319 11,983 $86K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 1,126 823 $81K
98 more codes
D1206 Topical application of fluoride varnish <1% 4,635 $64K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 11,756 $61K
80053 Comprehensive metabolic panel <1% 6,365 $44K
0071A <1% 1,147 $43K
0002A <1% 977 $43K
0072A <1% 1,019 $41K
G0071 Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only <1% 2,166 $40K
0001A <1% 866 $39K
96127 <1% 21,029 $35K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 508 $26K
0011A <1% 602 $23K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 537 $23K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 1,206 $23K
0012A <1% 434 $21K
84443 Thyroid stimulating hormone (TSH) <1% 1,674 $21K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 764 $20K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 2,824 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 765 $19K
99442 <1% 515 $16K
82948 <1% 8,133 $16K
0003A <1% 435 $15K
83655 <1% 1,014 $15K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 644 $15K
0013A <1% 468 $14K
99384 <1% 167 $11K
87536 <1% 438 $11K
84439 <1% 826 $9K
92551 <1% 13,435 $8K
90474 <1% 807 $8K
96161 <1% 2,263 $7K
77067 Screening mammography, bilateral, including computer-aided detection <1% 573 $7K
99383 <1% 60 $6K
84460 <1% 674 $5K
80048 Basic metabolic panel (calcium, ionized) <1% 718 $5K
90686 <1% 21,126 $5K
86803 <1% 298 $4K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 108 $3K
77063 Screening digital breast tomosynthesis, bilateral <1% 570 $3K
87428 <1% 92 $3K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) <1% 4,551 $3K
99173 <1% 13,685 $2K
99381 <1% 35 $2K
99441 <1% 84 $2K
90480 <1% 205 $2K
86361 <1% 75 $2K
96160 <1% 616 $2K
87081 <1% 237 $1K
71046 Radiologic examination, chest; 2 views <1% 156 $1K
86780 <1% 245 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 103 $1K
0031A <1% 21 $975.00
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 42 $714.85
D0140 Limited oral evaluation - problem focused <1% 13 $402.73
91322 <1% 19 $395.52
D0330 Panoramic radiographic image <1% 18 $309.75
G9919 Screening performed and positive and provision of recommendations <1% 25 $264.74
90651 <1% 2,151 $246.34
82465 <1% 41 $228.13
84153 <1% 12 $204.12
0064A <1% 17 $192.00
D0220 Intraoral - periapical first radiographic image <1% 18 $190.80
82728 <1% 12 $190.52
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 88 $159.31
83550 <1% 14 $111.10
83540 <1% 14 $82.40
85610 <1% 58 $80.00
84703 <1% 13 $66.41
90656 <1% 2,412 $39.10
91300 <1% 594 $12.86
91307 <1% 439 $8.40
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 16 $4.08
90723 <1% 3,427 $1.29
90647 0% 3,247 $0.00
G2025 Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only 0% 168 $0.00
90619 0% 459 $0.00
1000F 0% 804 $0.00
91301 0% 731 $0.00
90677 0% 835 $0.00
90716 0% 111 $0.00
90696 0% 37 $0.00
90744 0% 16 $0.00
76830 Ultrasound, transvaginal 0% 15 $0.00
91303 0% 18 $0.00
90670 0% 5,034 $0.00
90715 0% 356 $0.00
90633 0% 1,441 $0.00
90681 0% 848 $0.00
90734 0% 930 $0.00
1003F 0% 4,375 $0.00
90685 0% 193 $0.00
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 0% 254 $0.00
G9920 Screening performed and negative 0% 84 $0.00
90713 0% 14 $0.00
99078 0% 146 $0.00
90710 0% 38 $0.00
90707 0% 43 $0.00
99408 0% 19 $0.00
90700 0% 70 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFOYE, CLARETTA (CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under FOYE, CLARETTA

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.